Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARSIFAL: Palbociclib with Fulvestrant or Letrozole in Metastatic Breast Cancer
NCT02491983Phase 2Completed
- Sponsor
- MEDSIR
- Start
- Aug 2015
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of palbociclib in breast cancer, sponsored by MEDSIR. Started Aug 2015; status: completed.
02
Drugs
palbociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02491983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02491983.